Teva Pharmaceutical Q2 2021 Earnings Preview
- Teva Pharmaceutical (NYSE:TEVA) is scheduled to announce Q2 earnings results on Wednesday, July 28th, before market open.
- The consensus EPS Estimate is $0.59 (+7.3% Y/Y) and the consensus Revenue Estimate is $4.03B (+4.1% Y/Y).
- Over the last 2 years, TEVA…
